Common use of Authorization of Notes Clause in Contracts

Authorization of Notes. The Company will authorize the issue and sale of (a) $120,000,000 aggregate principal amount of its 4.18% Senior Notes, Series A, due September 30, 2026 (the “Series A Notes”) and

Authorization of Notes. The Company will authorize the issue and sale of of (a) $120,000,000 80,000,000 aggregate principal amount of its 4.186.71% Series A Senior NotesNotes due February 27, Series A, due September 30, 2026 2008 (the “"Series A Notes”") and (b) $20,000,000 aggregate principal amount of its 6.60% Series B Senior Notes due February 27, 2005 (the "Series B Notes").

Authorization of Notes. The Company will authorize the issue and sale of (a) $120,000,000 50,000,000 aggregate principal amount of its 4.187.09% Series A Senior NotesNotes due October 28, Series A, due September 30, 2026 2004 (the “"Series A Notes”) "), and

Authorization of Notes. The Company will authorize the issue and sale of (a) $120,000,000 50,000,000 aggregate principal amount of its 4.186.39% Senior Notes, Series A, due September 30April 1, 2026 2007 (the “"Series A Notes”) "); and

Authorization of Notes. The Company will authorize the issue and sale of of (a) $120,000,000 50,000,000 aggregate principal amount of its 4.184.70% Senior Notes, Series AJ, due September 30June 16, 2026 2011 (the “Series A J Notes”, such term to include any such notes issued in substitution therefore pursuant to Section 13); and (b) and$50,000,000 aggregate principal amount of its 5.04% Senior Notes, Series K, due June 16, 2012 (the “Series K Notes”, such term to include any such notes issued in substitution therefore pursuant to Section 13).

Authorization of Notes. The Company will authorize the issue and sale sale, in two series, of (a) $120,000,000 300,000,000 aggregate principal amount of its 4.18guaranteed senior notes, of which $150,000,000 aggregate principal amount shall be its 7.75% Series A Guaranteed Senior Notes, Series A, Notes due September 30, 2026 2004 (the “"Series A Notes”") andand $150,000,000 aggregate principal amount shall be its 7.87% Series B Guaranteed Senior Notes due 2007 (the "Series B Notes"). As used herein, the term "

Authorization of Notes. The Company will authorize the issue and sale of (ai) $120,000,000 35,000,000 aggregate principal amount of its 4.187.54% Senior Secured Notes, Series A, due September 30May 21, 2026 2009 (the “"Series A Notes”") andand (ii) $15,000,000 aggregate principal amount of its 7.76% Senior Secured Notes, Series B, due May 21, 2014 (the "Series B Notes" and together with the Series A Notes, the "Notes"). The term "

Authorization of Notes. The Company will authorize the issue and sale of (a) $120,000,000 225,000,000 aggregate principal amount of its 4.18senior notes consisting of (i) $53,000,000 aggregate principal amount 5.65% Series A Senior NotesUnsecured Notes due August 13, Series A, due September 30, 2026 2011 (the “Series A Notes”) and),

Authorization of Notes. The Company will authorize the issue and sale of of (a) $120,000,000 50,000,000 aggregate principal amount of its 4.186.70% Senior Notes, Series AL, due September 30July 13, 2026 2013 (the “Series A L Notes”, such term to include any such notes issued in substitution therefore pursuant to Section 13); and (b) and$25,000,000 aggregate principal amount of its 7.19% Senior Notes, Series M, due July 13, 2014 (the “Series M Notes”, such term to include any such notes issued in substitution therefore pursuant to Section 13).

Authorization of Notes. The Company will authorize the issue and sale of (a) $120,000,000 85,000,000 aggregate principal amount of its 4.18senior notes consisting of (i) $58,000,000 aggregate principal amount 4.15% Series D Senior NotesUnsecured Notes due March 5, Series A, due September 30, 2026 2015 (the “Series A D Notes” or the “Fixed Rate Notes”) and),

Authorization of Notes. The Company will authorize the issue and sale of (a) $120,000,000 50,000,000 aggregate principal amount of its 4.184.42% Senior Notes, Series AF, due September 30July 1, 2026 2007 (the “"Series A F Notes”) and", such term to include any such notes issued in substitution therefore pursuant to Section 13);

Authorization of Notes. The Company will authorize the issue and sale of of (a) $120,000,000 50,000,000 aggregate principal amount of its 4.183.97% Series A Senior NotesNotes due October 1, Series A, due September 30, 2026 2007 (the “"Series A Notes”"); (b) $30,000,000 aggregate principal amount of its 4.74% Series B Senior Notes due October 1, 2009 (the "Series B Notes"); and (c) $20,000,000 aggregate principal amount of its 5.05% Series C Senior Notes due October 1, 2010 (the "Series C Notes").

Authorization of Notes. The Company will authorize the issue and sale of (a) $120,000,000 135,000,000 aggregate principal amount of its 4.187.25% Senior Notes, Series A, due September 30, 2026 2007 (the “"SERIES A NOTES") and $25,000,000 aggregate principal amount of its 7.30% Senior Notes, Series B, due 2009 (the "SERIES B NOTES" and, together with the Series A Notes”, the "NOTES"), such notes to be substantially in the repective forms set out in Exhibits 1(a) andand 1(b). As used herein, the term "

Authorization of Notes. The Company will authorize the issue and sale of (a) $120,000,000 40,000,000 aggregate principal amount of its 4.184.67% Senior Notes, Series A, due September 30January 15, 2026 2021 (the “Series A Notes”) and),

Authorization of Notes. The Company will authorize the issue and sale of (ai) $120,000,000 35,000,000 aggregate principal amount of its 4.187.03% Senior Notes, Series A, due September 30August 1, 2026 2012 (the “"Series A Notes”") andand (ii) $15,000,000 aggregate principal amount of its 6.96% Senior Notes, Series B, due August 1, 2012 (the "Series B Notes", and together with the Series A Notes, the "Notes"). The term "

Authorization of Notes. The Company will authorize has duly authorized the issue and sale of (a) $120,000,000 155,000,000 aggregate principal amount of its 4.18Senior Unsecured Notes, to be issued in four series, in the respective designations and aggregate principal amounts set forth below: 5.95% Senior Unsecured Notes, Series A, due September 302017 $ 33,000,000 6.15% Senior Unsecured Notes, 2026 (the “Series A B, due 2022 $ 30,000,000 6.37% Senior Unsecured Notes”) and, Series C, due 2027 $ 42,000,000 6.47% Senior Unsecured Notes, Series D, due 2037 $ 50,000,000

Authorization of Notes. The Company will authorize the issue and sale of of: (a) $120,000,000 100,000,000 aggregate principal amount of its 4.183.73% Senior Guaranteed Notes, Series A, due September 30June 27, 2026 2008 (the “"Series A Notes”"); and (b) and$100,000,000 aggregate principal amount of its 4.33% Senior Guaranteed Notes, Series B, due June 27, 2010 (the "Series B Notes").

Authorization of Notes. The Company will authorize the issue and sale of (a) $120,000,000 235,000,000 aggregate principal amount of its 4.18senior notes consisting of (i) $75,000,000 aggregate principal amount of 2.74% Series DD Senior NotesUnsecured Notes due April 16, Series A, due September 30, 2026 2019 (the “Series A DD Notes”), (ii) and$50,000,000 aggregate principal amount of 3.20% Series EE Senior Unsecured Notes due April 16, 2021 (the “Series EE Notes”),